NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals' Q3 2025 Earnings Conference Call.
Nrx Pharmaceuticals Inc. (NRXP)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Anson Investments Amin Nathoo And Moez Kassam | 2,025,104 | $6,682,843 | +27% | 0.61% |
| 2. | Marshall Wace LLP Paul Marshall And Ian Wace | 189,136 | $624,150 | +467% | 0% |
| 3. | Renaissance Technologies Jim Simons | 128,175 | $422,978 | 0% | |
| 4. | 32,900 | $108,570 | 0% | ||
| 5. | Citadel Investment Group Ken Griffin | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.17 | 40,000 | $46,800.00 | 84,634 | 2024-12-17 | Filing | |
| $0.32 | 35,000 | $11,196.50 | 105,000 | 2023-08-30 | Filing | |
| $0.29 | 70,000 | $20,125.00 | 570,000 | 2023-08-30 | Filing | |
| $0.33 | 100,000 | $33,000.00 | 446,332 | 2023-08-23 | Filing | |
| $0.32 | 200,000 | $64,400.00 | 346,332 | 2023-08-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.00 | 400,000 | $400,000.00 | 12,899,997 | 2022-12-07 | Filing | |
| $1.50 | 8,441 | $12,700.33 | 9,634,793 | 2022-11-30 | Filing | |
| $1.50 | 13,730 | $20,651.29 | 9,643,234 | 2022-11-29 | Filing | |
| $1.05 | 33,018 | $34,744.84 | 9,656,964 | 2022-11-17 | Filing | |
| $1.02 | 133,719 | $136,393.38 | 9,689,982 | 2022-11-16 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,000,000 | $4,455,000 | 3.28% | |
| 2. | 534,956 | $1,765,355 | 0% | |
| 3. | 342,136 | $1,129,049 | 0.18% | |
| 4. | 185,862 | $613,455 | 0% | |
| 5. | 152,848 | $504,399 | 0% |
News See All
NRx Pharmaceuticals, Inc. (NRXP)’ NRX-100 Wins Expanded FDA Fast Track for Suicidal Depression
NRx Pharmaceuticals, Inc.
13 Best Psychedelic Stocks to Invest in Now
Unlike drugs such as cocaine or marijuana, psychedelics create an “alternate reality” by altering feelings, thoughts, and energy levels.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2025 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen. Welcome to NRx Pharmaceuticals Q2 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, August 20, 2025.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx Pharmaceuticals First Quarter 2025 Earnings Call. At this time, all lines are in a listen-only mode.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q4 2024 Earnings Call Transcript
Operator: Good morning, ladies and gentlemen, and welcome to the NRx Pharmaceuticals 4Q and Full Year 2024 Earnings Call. At this time, all lines are in a listen only mode.
12 Best Psychedelic Stocks to Buy in 2025
In contrast to drugs like cocaine or marijuana, psychedelics are strong and give users access to a kind of "alternate reality." One class of hallucinogenic substances that can produce unusual states of...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the NRx Pharmaceuticals Third Quarter 2024 Earnings Conference Call. At this time, all lines are in the listen-only mode.
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Q2 2024 Earnings Call Transcript
Operator: Good afternoon, everyone. And welcome to the NRx Pharmaceuticals Incorporated Second Quarter of 2024 Results Conference Call. Currently, all participants are in a listen-only mode.